Namenda and Lenalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Namenda (memantine hydrochloride) and Lenalidomide (lenalidomide). Common drug interactions include light chain analysis increased among females and pain in extremity among males.

The phase IV clinical study analyzes what interactions people have when they take Namenda and Lenalidomide. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Namenda?

Namenda has active ingredients of memantine hydrochloride. It is often used in dementia. eHealthMe is studying from 14,283 Namenda users. Check the latest studies of Namenda.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.

On Jul, 11, 2026

21 people who take Namenda and Lenalidomide together, and have interactions are studied.

Namenda and Lenalidomide drug interactions.

What are the common drug interactions of Namenda and Lenalidomide, by gender? *:

female:

Light chain analysis increased
Abdominal discomfort
Abdominal pain upper
Alopecia (absence of hair from areas of the body)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Constipation
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Hyperglycaemia (high blood sugar)
Influenza

male:

Pain in extremity
Pyrexia (fever)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Gout (uric acid crystals building up in the body)
Haemoglobin decreased
Hypotension (abnormally low blood pressure)
Mouth breathing (breathing through mouth)

What are the common drug interactions of Namenda and Lenalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)

10-19:

Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Pain in extremity
Pyrexia (fever)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Burning sensation
Chills (felling of cold)
Confusional state
Constipation
Cough
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dehydration (dryness resulting from the removal of water)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 12 people, 57.14%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 14.29%
Lymphoma (cancer that begins in immune system cells): 2 people, 9.52%
Autism (a mental condition, present from early childhood, characterized by difficulty in communicating and forming relationships with other people and in using language and abstract concepts): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Namenda and Lenalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously